Aberdeen Asset Management’s Merck MRK Stock Holding History

Aberdeen Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$103M	Buy	1,683,019 +130,944	+8%	+$7.97M	0.34%	56
2017 Q1	$94.1M	Buy	1,552,075 +31,832	+2%	+$1.93M	0.33%	55
2016 Q4	$85.4M	Sell	1,520,243 -59,304	-4%	-$3.47M	0.33%	57
2016 Q3	$94.1M	Sell	1,579,547 -24,565	-2%	-$1.44M	0.34%	51
2016 Q2	$88.2M	Sell	1,604,112 -27,073	-2%	-$1.44M	0.33%	49
2016 Q1	$82.4M	Sell	1,631,185 -89,439	-5%	-$4.38M	0.3%	53
2015 Q4	$85.4M	Buy	1,720,624 +24,346	+1%	+$1.23M	0.29%	56
2015 Q3	$79.9M	Sell	1,696,278 -43,322	-2%	-$2.3M	0.27%	59
2015 Q2	$94.5M	Sell	1,739,600 -37,222	-2%	-$2.09M	0.27%	52
2015 Q1	$97.5M	Sell	1,776,822 -52,137	-3%	-$2.95M	0.26%	52
2014 Q4	$99.1M	Sell	1,828,959 -330,392	-15%	-$18.4M	0.25%	51
2014 Q3	$122M	Sell	2,159,351 -126,812	-6%	-$7.12M	0.27%	51
2014 Q2	$126M	Buy	2,286,163 +1,964,514	+611%	+$107M	0.26%	53
2014 Q1	$17.4M	Sell	321,649 -1,362	-0.4%	-$70.5K	0.05%	105
2013 Q4	$15.3M	Hold	323,011	–	–	0.04%	111
2013 Q3	$14.7M	Sell	323,011 -48,366	-13%	-$2.21M	0.04%	105
2013 Q2	$16.5M	Buy	+371,377	New	+$16.6M	0.05%	85

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Asset Management's MRK Position: Q2 2017 in Review

Aberdeen Asset Management increased its Merck (MRK) stake by 8.4% in Q2 2017, buying an estimated $7.97M and bringing the position to 1,683,019 shares worth $103M. The position accounts for 0.34% of the portfolio, ranked #56.

Aberdeen Asset Management first reported a position in MRK in Q2 2013 and has held it in 17 quarters since. The position peaked at $126M in Q2 2014. 1,926 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

Aberdeen Asset Management held 1,683,019 shares of Merck worth $103M as of Q2 2017.
Aberdeen Asset Management bought 130,944 Merck shares in Q2 2017, an estimated $7.97M.
Merck made up 0.34% of Aberdeen Asset Management's portfolio in Q2 2017, its #56 holding.
Aberdeen Asset Management first reported a position in Merck in Q2 2013 and has held it in 17 quarters since.
Aberdeen Asset Management's Merck position peaked at $126M in Q2 2014.
1,926 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.